Extending Your Interdisciplinary Understanding of IL-6R Inhibitors in Rheumatoid Arthritis

New Targets, New Hope in SMA: A 2020 Congress Coverage

Identifying Barriers to and Developing Opportunities for Rotavirus Vaccination

Weighing Evidence and Perspectives on JAK Inhibitors in Psoriatic Arthritis: Can We Do More for Patients?

"Optimising the Use of JAK Inhibitors in RA: Translating the Latest Evidence Into Today’s Clinical Practice"

Talking Meningococcal B Vaccines: Who Needs Protecting Now?

Visit https://www.peervoice.com/AHQ860 to view the entire programme with slides. After completing “Going Below the Surface in Advanced Basal Cell Carcinoma: Analysing the Latest Evidence”, participants will be able to: Describe the role of immunotherapy options for advanced BCC; Evaluate the most current clinical evidence for these options in terms of efficacy and safety; and Describe the clinical implications of these options on the treatment paradigm for advanced BCC, from an interdisciplinary perspective.

Early Disease Control in Inflammatory Bowel Disease: Integrating the Latest Evidence for Better Outcomes

Managing Youth-Onset Type 2 Diabetes: What Paediatricians Need to Know

Patient Scenarios in Rheumatoid Arthritis: Optimising Remission With JAK Inhibitors